NEK1-Mediated Phosphorylation of YAP1 Is Key to Prostate Cancer Progression

Understanding how Androgen-dependent PCa cells progress to independence and modify accordingly their transcriptional repertoire is the key to preventing mCRPC progression. We recently identified a novel axis of the Hippo pathway characterized by the sequential kinase cascade induced by androgen deprivation: AR−>TLK1B>NEK1>pYAP1-Y407 leading to CRPC adaptation. Phosphorylation of YAP-Y407 increases upon ADT or induction of DNA damage, correlated with the known increase in NEK1 expression/activity, and this is suppressed in the Y407F mutant. Dominant expression of YAP1-Y407F in Hek293 cells reprograms the YAP1-mediated transcriptome to reduced TEAD- and P73-regulated gene expression and mediates sensitivity to MMC. NEK1 haploinsufficient TRAMP mice display reduced YAP1 expression and if castrated fail to progress to overt prostate carcinomas, even while displaying reduced E-CAD expression in hyperplastic ductules. YAP1 overexpression, but not the Y407F mutant, transforms LNCaP cells to androgen independent growth and a mesenchymal morphology. Immunohistochemical examination of Prostate Cancer biopsies revealed that pYAP1-Y407 nuclear signal is low in samples of low-grade cancer but elevated in high GS specimens. We also found that J54, pharmacological inhibitor of the TLK1>NEK1>YAP1 nexus, leading to degradation of YAP1 can suppress the transcriptional reprogramming of LNCaP cells to Androgen-Independent growth and EMT progression even when YAP1-WT is overexpressed.

[1]  A. Regev,et al.  Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis , 2022, Nature Cell Biology.

[2]  A. De Benedetti,et al.  TLK1‐mediated MK5‐S354 phosphorylation drives prostate cancer cell motility and may signify distinct pathologies , 2022, Molecular oncology.

[3]  A. De Benedetti,et al.  Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance , 2022, Cancer drug resistance.

[4]  K. Domsch,et al.  Twist regulates Yorkie activity to guide lineage reprogramming of syncytial alary muscles. , 2022, Cell reports.

[5]  S. Mahajan,et al.  Riluzole-induced apoptosis in osteosarcoma is mediated through Yes-associated protein upon phosphorylation by c-Abl Kinase , 2021, Scientific Reports.

[6]  A. De Benedetti,et al.  NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output , 2020, Cancers.

[7]  A. De Benedetti,et al.  Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy , 2020, iScience.

[8]  R. Zou,et al.  YAP nuclear‐cytoplasmic translocation is regulated by mechanical signaling, protein modification, and metabolism , 2020, Cell biology international.

[9]  A. De Benedetti,et al.  The TLK1-Nek1 axis promotes prostate cancer progression. , 2019, Cancer letters.

[10]  A. Dey,et al.  Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities. , 2019, Trends in cancer.

[11]  C. G. Hansen,et al.  The Hippo Pathway in Prostate Cancer , 2019, Cells.

[12]  Brian A. Joughin,et al.  Comprehensive substrate specificity profiling of the human Nek kinome reveals unexpected signaling outputs , 2019, bioRxiv.

[13]  S. Piccolo,et al.  YAP/TAZ upstream signals and downstream responses , 2018, Nature Cell Biology.

[14]  Yang Jiang,et al.  YAP Promotes Migration and Invasion of Human Glioma Cells , 2018, Journal of Molecular Neuroscience.

[15]  E. Hwang,et al.  Yes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma , 2017, Journal of pathology and translational medicine.

[16]  Jorge Oliver-De La Cruz,et al.  YAP regulates cell mechanics by controlling focal adhesion assembly , 2017, Nature Communications.

[17]  A. De Benedetti,et al.  Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity , 2017, Cell cycle.

[18]  B. Zhou,et al.  Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway , 2016, Scientific Reports.

[19]  Bin Zhao,et al.  Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer , 2015, Cell.

[20]  I. Garraway,et al.  YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer , 2015, Nature Communications.

[21]  P. Nelson,et al.  ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors. , 2015, Cancer cell.

[22]  Nicholas Y. Palermo,et al.  The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells , 2015, Molecular and Cellular Biology.

[23]  S. Dupont,et al.  The biology of YAP/TAZ: hippo signaling and beyond. , 2014, Physiological reviews.

[24]  E. Hwang,et al.  TAZ Suppresses NFAT5 Activity through Tyrosine Phosphorylation , 2012, Molecular and Cellular Biology.

[25]  M. Sudol,et al.  Structures of YAP protein domains reveal promising targets for development of new cancer drugs. , 2012, Seminars in cell & developmental biology.

[26]  A. G. de Herreros,et al.  Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition* , 2011, The Journal of Biological Chemistry.

[27]  Li Li,et al.  The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. , 2010, Genes & development.

[28]  P. Pandolfi,et al.  PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. , 2008, Molecular cell.

[29]  Y. Shaul,et al.  Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. , 2008, Molecular cell.

[30]  Zhengyu Zha,et al.  TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway , 2008, Molecular and Cellular Biology.

[31]  Y. Shaul,et al.  The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73 , 2007, Cell Death and Differentiation.

[32]  S. Tsuriel,et al.  Nek1 shares structural and functional similarities with NIMA kinase. , 2006, Biochimica et biophysica acta.

[33]  T. Golub,et al.  Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer. , 2005, The Journal of urology.

[34]  D. Riley,et al.  NIMA-Related Protein Kinase 1 Is Involved Early in the Ionizing Radiation-Induced DNA Damage Response , 2004, Cancer Research.

[35]  R. Walmsley,et al.  DNA-damage induction of RAD54 can be regulated independently of the RAD9- and DDC1-dependent checkpoints that regulate RNR2 , 2002, Current Genetics.

[36]  R. Nagle,et al.  N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. , 1999, The American journal of pathology.

[37]  J. Plumb,et al.  Sensitivity of cell lines to mitomycin C. , 1996, British journal of urology.

[38]  T. Pawson,et al.  A mammalian dual specificity protein kinase, Nek1, is related to the NIMA cell cycle regulator and highly expressed in meiotic germ cells. , 1992, The EMBO journal.

[39]  K. Guan,et al.  A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). , 2010, Genes & development.

[40]  J. Downward,et al.  Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. , 2003, Molecular cell.